Your browser doesn't support javascript.
loading
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF.
Jiménez-Vicente, Carlos; Martínez-Roca, Alexandra; Pomares, Helena; Castaño-Diez, Sandra; Guijarro, Francesca; López-Guerra, Mònica; Bataller, Alex; Esteban, Daniel; Cortés-Bullich, Albert; Pérez-Valencia, Amanda Isabel; Guardia-Torrelles, Ares; Zugasti, Inés; Rovira, Montserrat; Fernández-Avilés, Francesc; Colomer, Dolors; Arnan, Montserrat; Díaz-Beyá, Marina; Esteve, Jordi.
Afiliação
  • Jiménez-Vicente C; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain.
  • Martínez-Roca A; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Pomares H; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain; Hematology Department, Institut Català d'Oncologia - Hospital Duran i Reynals, Universitat de Barcelona, Barcelona, Spain.
  • Castaño-Diez S; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Guijarro F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department. Hospital Clinic Barcelona, Spain.
  • López-Guerra M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department. Hospital Clinic Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Bataller A; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Josep Carreras Leukemia Research Institute, Barcelona, Spain.
  • Esteban D; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Cortés-Bullich A; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Pérez-Valencia AI; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Guardia-Torrelles A; Hematology Department, Hospital Clínic Barcelona, Spain.
  • Zugasti I; Hematology Department, Hospital Clínic Barcelona, Spain.
  • Rovira M; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain.
  • Fernández-Avilés F; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Colomer D; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Hemopathology Unit, Pathology Department, Hospital Clínic de Barcelona, Spain.
  • Arnan M; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain; Hematology Department, Institut Català d'Oncologia - Hospital Duran i Reynals, Universitat de Barcelona, Barcelona, Spain.
  • Díaz-Beyá M; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Josep Carreras Leukemia Research Institute, Barcelona, Spain.
  • Esteve J; Hematology Department, Hospital Clínic Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona, Barcelona, Spain; Josep Carreras Leukemia Research Institute, Barcelona, Spain. Electronic address: jesteve@clinic.cat.
Leuk Res ; 135: 107403, 2023 12.
Article em En | MEDLINE | ID: mdl-37837718
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans Idioma: En Revista: Leuk Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Limite: Humans Idioma: En Revista: Leuk Res Ano de publicação: 2023 Tipo de documento: Article